Last reviewed · How we verify
Eutectic Lidocaine Prilocaine
At a glance
| Generic name | Eutectic Lidocaine Prilocaine |
|---|---|
| Also known as | EMLA |
| Sponsor | Augusta University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Virtual Reality for Port-a-Cath Access (NA)
- EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers (PHASE2)
- Comparative Study of Two Topical Anesthetics Prior to Fractional Nonablative Laser Treatment of the Face (PHASE2, PHASE3)
- Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment (PHASE1, PHASE2)
- The Effectiveness of Herbal Creams Compared to Urea in Dry Skin Treatment (PHASE1, PHASE2)
- Evaluation of Paro, a Therapeutic Assistance Robot in Analgesic Management During the Placement of a Peripheral Intravenous Line in Infants and Children. (NA)
- Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE) (PHASE4)
- Emla-Cream as Pain Relief During Pneumococcal Vaccination (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Eutectic Lidocaine Prilocaine CI brief — competitive landscape report
- Eutectic Lidocaine Prilocaine updates RSS · CI watch RSS
- Augusta University portfolio CI